http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-0169195-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fa4c37b4aacb317ee027a1a729de4ff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-00 |
| filingDate | 1996-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c73f92276cb64c7ffe0bbd3b76589f83 |
| publicationDate | 1999-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-0169195-B1 |
| titleOfInvention | PVMA-Ara-C conjugate |
| abstract | The present invention relates to a PVMA-Ara-C conjugate, and more particularly, to a PVMA-Ara-C conjugate represented by the following structural formula (I), which maintains drug concentrations for a long time in a single administration to enhance an anticancer effect, and a method of preparing the same. And it relates to an anticancer agent containing it as an active ingredient.n n n n n n n n In the above formula, the ratio of x and y is 0: 100 to 80:20. |
| priorityDate | 1996-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.